arrow
R

Rachel Goodwin

The Ottawa Hospital
H指数:26
被引数:2,930

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma

多组学全基因组表征转移性胰腺导管腺癌的拷贝数景观

2025-07-220
OA
Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis

中性粒细胞胞外陷阱基因表达特征识别用于抑制胰腺肿瘤转移的预后和可靶向信号轴

2025-07-040
OAAI
BOLD-100-001 (TRIO039): a phase 1b/2a dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pre-treated advanced colorectal cancer: interim efficacy, safety and tolerability analysis
2023-04-144
PRE
Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma

KRAS野生型转移性胰腺导管腺癌的综合分析揭示了与胆管癌的突变和基于表达的相似性

2022-10-0819
OAAI
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

富含DNA修复缺陷的晚期实体瘤患者CX-5461的I期CCTG IND.231试验结果

2022-06-2463
OAAI
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?
2021-01-0421
OAAI
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper

ctDNA在结直肠癌中的应用和整合: NCI结肠和直肠-肛门工作组白皮书

2020-07-06233
OAAI
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

腺苷2A受体阻断作为治疗难治性肾细胞癌的免疫疗法

2020-01-09236
OAAI